Cerevel Therapeutics Inc...

44.96
0.33 (0.74%)
At close: Jul 31, 2024, 8:00 PM

Cerevel Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
n/a n/a n/a n/a n/a n/a
5.63M 4.9M 2.73M 397K n/a n/a
-5.63M -4.9M -2.73M -397K n/a n/a
-447.26M -367.85M -220.1M -149.12M -83.46M -483.32M
43.87M 9.62M 157K 224K 1.55M 2.04K
-432.34M -351.35M -225.33M -152.17M -128.34M -463.64M
-432.84M -351.51M -222.45M -152.14M -128.39M -463.64M
112.62M 87.59M 58.24M 45.81M 33.17M 28.67M
334.64M 280.26M 161.85M 103.3M 50.29M 454.65M
n/a 6.88M -5.39M -3.27M 9K n/a
465.64M 367.85M 220.1M 149.12M 83.46M 465.67M
10.57M 9.62M n/a n/a n/a n/a
-5.63M n/a n/a n/a n/a n/a
465.64M 367.85M 220.1M 149.12M 83.46M 465.67M
503K 160K -2.89M -24K 45K -161.06K
162.06M 151.27M 136.58M 73.64M 127.12M 2.81M
162.06M 151.27M 136.58M 73.64M 127.12M 2.81M
-2.67 -2.32 -1.63 -2.07 -1.01 -164.94
-2.67 -2.32 -1.63 -2.07 -1.01 -164.93
-441.64M -367.85M -211.98M -148.72M -36.84M -483.25M
-421.77M -341.73M n/a n/a n/a n/a
5.63M 4.9M 2.73M 397K 177K 76K